Compound information
- Natural Products
- ZC1968708
- Molecular Formula
- C19H30N2O4S
- Molecular Weight
- 382.19262844 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-butylphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C19H30N2O4S/c1-5-6-7-16-8-10-17(11-9-16)26(23,24)21-14-12-20(13-15-21)18(22)25-19(2,3)4/h8-11H,5-7,12-15H2,1-4H3
- InChI Key
- ADVAXSIQIAOCKS-UHFFFAOYSA-N
- SMILES
- CCCCc1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1
- Source
- ZINC000017078166
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 4.245 |
LogS | -5.09 | LogD | 4.062 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.728 | Pgp substrate | 0.014 |
HIA | 0.969 | F20 % | 0.987 |
F30 % | 0.97 | Caco-2 | -4.362 |
MDCK | -4.851 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.886 | PPB | 99.018 |
VD | 2.299 | Fu | 1.314 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.095 | CYP1A2 substrate | 0.54 |
CYP2A6 substrate | 0.709 | CYP2B6 substrate | 0.7 |
CYP2C19 inhibitor | 0.946 | CYP2C19 substrate | 0.796 |
CYP2C8 substrate | 0.617 | CYP2C9 inhibitor | 0.86 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.178 |
CYP2D6 substrate | 0.772 | CYP2E1 substrate | 0.713 |
CYP3A4 inhibitor | 0.338 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.209 | CL | 6.678 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.993 | Hepatotoxicity | 0.789 |
Mutagenicity | 0.048 | Rat Oral Acute Toxicity | 0.15 |
FDAMDD | 0.09 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.708 | Eye Corrosion | 0.005 |
Eye Irritation | 0.026 | Respiratory Toxicity | 0.672 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.511 | IGC50 | 3.974 |
LC50FM | 3.243 | LC50DM | 2.966 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.171 | NR-AR-LBD | 0.254 |
NR-AhR | 0.033 | NR-Aromatase | 0.873 |
NR-ER | 0.262 | NR-ER-LBD | 0.411 |
NR-PPAR-gamma | 0.16 | SR-ARE | 0.77 |
SR-ATAD5 | 0.369 | SR-HSE | 0.12 |
SR-MMP | 0.113 | SR-p53 | 0.03 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.